Triumvira Immunologics to Showcase Promising T Cell Therapy Data at 2025 SITC Conference Triumvira Immunologics is set to present updated clinical findings on its innovative T cell therapies for solid tumors at the 2025 SITC Conference.

Triumvira Immunologics to Showcase Promising T Cell Therapy Data at 2025 SITC Conference #United_States #San_Diego #Triumvira #SITC #T_Cell

Vaccine to prevent pancreatic, colorectal cancer relapse yields ‘exciting’ early results Results of a phase 1 trial for a vaccine targeting micrometastatic disease markers in patients already treated for pancreatic or colorectal cancer showed potential in preventing recurrence, according ...

#Vaccine to prevent #pancreatic, #colorectalcancer relapse yields ‘exciting’ early results (84% of patients had a positive #T_cell response): @muschollings www.healio.com/news/hematol...